Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune neuropathy characterised by insidious onset, progressive course, proximal and distal symmetrical weakness, and sensory impairment. It may affect patients of any age with varying degrees of clinical involvement and resp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Rocha, Raquel, Correia, Filipe, Santos, Andreia, Martins, João
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2020
Schlagworte:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7451476/
https://ncbi.nlm.nih.gov/pubmed/32847874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-234681
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge